NCT07334535 2026-01-13
Isa-VRD in TIE HRMM
Peking Union Medical College Hospital
Phase 4 Not yet recruiting
Clinical Trials
9 trialsNCT03829371 2025-12-03
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA
University of Turin, Italy
Phase 4 Active not recruiting
NCT07025005 2025-11-04
VRd MM Fibrate
Tanta University
Phase 4 Recruiting
NCT02773550 2020-01-18
Velcadito
Basque Health Service
Phase 4 Terminated
NCT02559154 2018-05-04
Modified Bortezomib-based Combination Therapy for Multiple Myeloma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT02268890 2016-07-11
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
Johnson & Johnson Taiwan Ltd
Phase 4 Completed
NCT00652041 2011-09-19
TaCyDexVMP7
PETHEMA Foundation
Phase 4 Completed
NCT01249690 2010-11-30
Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma
Second Military Medical University
Phase 4 Unknown
NCT00257114 2008-02-11
Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability
Millennium Pharmaceuticals, Inc.
Phase 4 Completed